{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:57:49Z","timestamp":1790355469151,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To identify the incidence of, risk factors for, and outcomes of posterior segment complications (PSC) after Boston Type 1 keratoprosthesis (KPro) implantation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Retrospective, consecutive case series of KPro procedures at the Stein Eye Institute. Data regarding ocular history, intraoperative details, postoperative management, and outcomes were collected. Eyes with at least one PSC (PSC group) were compared with eyes without PSC (No PSC group), and risk factors for PSC were determined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Ninety-five PSC occurred in 69\/169 eyes (40.8%), at a mean of 20.1 months after KPro implantation (0.01 complications\/eye month). The median follow-up after KPro implantation was 44.0 months (range 3.0\u2013174.4). The most common PSC were epiretinal membrane (16.6%), cystoid macular edema (12.4%), vitritis (11.2%), and retinal detachment (9.5%). Previous retinal detachment repair, concomitant intraocular lens removal, postoperative aphakia, and vitritis were risk factors for retinal detachment. Postoperative infectious keratitis was a risk factor for epiretinal membrane, cystoid macular edema, and vitritis. The posterior segment complication group had a significantly higher rate of eyes failing to maintain visual acuity \u226520\/200 (HR = 2.28; 95% CI = 1.35\u20133.85) and KPro retention failure rate (HR = 1.66; 95% CI = 0.95\u20132.91).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Posterior segment complications occur in approximately 40% of eyes after KPro implantation, resulting in reduced visual outcomes and KPro retention.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003233","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T23:04:09Z","timestamp":1623366249000},"page":"2499-2509","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["POSTOPERATIVE POSTERIOR SEGMENT COMPLICATIONS AFTER BOSTON TYPE 1 KERATOPROSTHESIS"],"prefix":"10.1097","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1732-7643","authenticated-orcid":false,"given":"Cl\u00e9mence","family":"Bonnet","sequence":"first","affiliation":[{"name":"Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, California;"},{"name":"Ophthalmology Department, Cochin Hospital, AP-HP, Paris University, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"Chehaibou","sequence":"additional","affiliation":[{"name":"Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, California;"},{"name":"Ophthalmology Department, Universite\u0301 de Paris, AP-HP, Ho\u0302pital Lariboisi\u00e8re, Paris; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Chen","sequence":"additional","affiliation":[{"name":"Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Bourges","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Cochin Hospital, AP-HP, Paris University, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Markovic","sequence":"additional","affiliation":[{"name":"Department of Medicine Statistics Core, University of California, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Hubschman","sequence":"additional","affiliation":[{"name":"Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Aldave","sequence":"additional","affiliation":[{"name":"Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250607","first-page":"1601","article-title":"Long-term visual outcomes of the Boston type I keratoprosthesis in Canada","volume":"104","author":"Szigiato","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/ICO.0000000000001405","article-title":"Long-term visual outcomes, complications, and retention of the Boston type I keratoprosthesis","volume":"37","author":"Aravena","year":"2018","journal-title":"Cornea"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ajo.2014.12.024","article-title":"Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation","volume":"159","author":"Ahmad","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R4-20250607","article-title":"Infectious keratitis after Boston type 1 keratoprosthesis implantation","author":"Ghaffari","year":"2020","journal-title":"Cornea"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.ophtha.2013.05.001","article-title":"Microbial keratitis after Boston type I keratoprosthesis implantation: incidence, organisms, risk factors, and outcomes","volume":"120","author":"Kim","year":"2013","journal-title":"Ophthalmology"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ophtha.2016.08.003","article-title":"Safety of concurrent Boston type I keratoprosthesis and glaucoma drainage device implantation","volume":"124","author":"Lenis","year":"2017","journal-title":"Ophthalmology"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"e546","DOI":"10.1111\/aos.12309","article-title":"Infectious endophthalmitis in Boston keratoprosthesis: incidence and prevention","volume":"92","author":"Behlau","year":"2014","journal-title":"Acta ophthalmologica"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/IAE.0b013e3182641848","article-title":"Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis","volume":"33","author":"Goldman","year":"2013","journal-title":"Retina"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.survophthal.2014.11.001","article-title":"Vitreoretinal aspects of permanent keratoprosthesis","volume":"60","author":"Klufas","year":"2015","journal-title":"Surv Ophthalmol"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/ICO.0000000000001983","article-title":"Posterior segment complications and impact on long-term visual outcomes in eyes with a type 1 Boston keratoprosthesis","volume":"38","author":"Moshiri","year":"2019","journal-title":"Cornea"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1097\/IAE.0000000000002036","article-title":"Comparison of visual and anatomical outcomes of eyes undergoing type 1 boston keratoprosthesis with combination pars plana vitrectomy with eyes without combination vitrectomy","volume":"38","author":"Lim","year":"2018","journal-title":"Retina"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.oret.2018.04.010","article-title":"Vitritis after Boston keratoprosthesis type 1 implantation","volume":"2","author":"Johnson","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/bjophthalmol-2018-312426","article-title":"Keratoprostheses in silicone oil-filled eyes: long-term outcomes","volume":"103","author":"Iyer","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ophtha.2008.12.058","article-title":"The Boston type I keratoprosthesis: improving outcomes and expanding indications","volume":"116","author":"Aldave","year":"2009","journal-title":"Ophthalmology"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/01.ico.0000159736.60424.ff","article-title":"Sudden reversible vitritis after keratoprosthesis: an immune phenomenon?","volume":"24","author":"Nouri","year":"2005","journal-title":"Cornea"},{"key":"R16-20250607","article-title":"Idiopathic vitritis after Boston type 1 keratoprosthesis implantation: incidence, risk factors and outcomes in a multicentric cohort","author":"Bonnet","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.ophtha.2010.12.032","article-title":"Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis","volume":"118","author":"Greiner","year":"2011","journal-title":"Ophthalmology"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archophthalmol.2011.1115","article-title":"Vitreoretinal surgery in the setting of permanent keratoprosthesis","volume":"130","author":"Kiang","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ophtha.2017.04.016","article-title":"Impact of total pars plana vitrectomy on postoperative complications in aphakic, snap-on, type 1 Boston keratoprosthesis","volume":"124","author":"Perez","year":"2017","journal-title":"Ophthalmology"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1097\/IAE.0000000000001049","article-title":"Vitreoretinal complications after penetrating keratoplasty","volume":"36","author":"Park","year":"2016","journal-title":"Retina"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/bjophthalmol-2015-307729","article-title":"Risk factors for retinal detachment following cataract surgery: the impact of posterior capsular rupture","volume":"100","author":"Petousis","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1076\/soph.17.3.206.14784","article-title":"Biostatistical analysis of pseudophakic and aphakic retinal detachments","volume":"17","author":"Ramos","year":"2002","journal-title":"Semin Ophthalmol"},{"key":"R23-20250607","first-page":"101","article-title":"The pathogenesis of aphakic retinal detachment","volume":"16","author":"Irvine","year":"1985","journal-title":"Ophthalmic Surg"},{"key":"R24-20250607","first-page":"1","article-title":"Retinal detachments after Boston Keratoprosthesis: incidence, predisposing factors, and visual outcomes","volume":"21","author":"Jardeleza","year":"2015","journal-title":"Digital J Ophthalmol"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003226-200101000-00003","article-title":"Keratoprosthesis: preoperative prognostic categories","volume":"20","author":"Yaghouti","year":"2001","journal-title":"Cornea"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/ICO.0b013e31818b8bfa","article-title":"Boston type 1 keratoprosthesis: the university of California davis experience","volume":"28","author":"Bradley","year":"2009","journal-title":"Cornea"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/09273948.2018.1424343","article-title":"Risk factors for development of rhegmatogenous retinal detachment in patients with uveitis","volume":"27","author":"Kunavisarut","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/ICO.0000000000000911","article-title":"Incidence, risk factors, and surgical management of Boston type 1 keratoprothesis corneal melts, leaks, and extrusions","volume":"35","author":"Chan","year":"2016","journal-title":"Cornea"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/09273948.2016.1269930","article-title":"Corneal melt after Boston keratoprosthesis: clinical presentation, management, outcomes and risk factor analysis","volume":"26","author":"Bouhout","year":"2018","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:05:50Z","timestamp":1749319550000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003233"}},"subtitle":["Incidence, Risk Factors, and Intermediate-Term Outcomes"],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003233","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}